DS-8201a
D9673C00007
Approved small_molecule active
Quick answer
DS-8201a for Treatment of patients with HER2-positive breast cancer with or without brain metastasis is a Approved program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Treatment of patients with HER2-positive breast cancer with or without brain metastasis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active